Legacy Capital Wealth Partners, LLC Astrazeneca PLC Transaction History
Legacy Capital Wealth Partners, LLC
- $574 Million
- Q3 2024
A detailed history of Legacy Capital Wealth Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Legacy Capital Wealth Partners, LLC holds 9,240 shares of AZN stock, worth $589,512. This represents 0.13% of its overall portfolio holdings.
Number of Shares
9,240
Previous 9,028
2.35%
Holding current value
$589,512
Previous $704,000
2.13%
% of portfolio
0.13%
Previous 0.18%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.01 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.68 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.38 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.35 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.23 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $198B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...